logo
Eating More of These Foods May Lower Your Cancer Risk by 8%, New Study Suggests

Eating More of These Foods May Lower Your Cancer Risk by 8%, New Study Suggests

Yahoo07-06-2025
Reviewed by Dietitian Annie Nguyen, M.A., RDA new study suggests that eating flavonoid-rich foods supports lower risks of cancer and other diseases.
Flavonoids are compounds found in fruits, vegetables, tea and other plant-based foods.
Tea, berries, apples and oranges were among the top sources of flavonoids in the study.Cancer is one of the leading causes of death, and rates of certain types—including colon and pancreatic cancers—are on the rise, especially among younger adults. While there's no magic bullet to prevent it, diet remains one of the best tools you have to lower your cancer risk. For years, scientists have studied how specific nutrients and plant compounds may help reduce inflammation, combat oxidative stress and even interfere with the growth of cancer cells.
Flavonoids—the natural compounds found in colorful fruits, vegetables, tea and other plant-based foods—have gotten special attention from researchers. Past studies have linked high flavonoid intake to better heart health, improved blood sugar regulation, and possibly lower cancer risk. But until now, few studies have looked at the diversity of flavonoids people eat—not just how much they consume.
A new study published in Nature Food takes that next step. It found that people who consumed a wider variety of flavonoid-rich foods had a lower risk of dying from any cause and were less likely to develop chronic diseases like heart disease, type 2 diabetes—and even cancer. The findings suggest that expanding the range of flavonoid-rich foods in your diet may offer more protection than sticking to just a few favorites.
Let's take a closer look at what the study found—and what it means for your health.
Researchers analyzed data from more than 124,000 adults enrolled in the UK Biobank, a long-term health study. Participants were between 40 and 69 years old at the time of enrollment and were followed for up to 11.8 years.
To assess diet, the researchers used 24-hour dietary recall surveys that captured participants' intake of various foods and beverages. They specifically focused on flavonoids—a class of compounds found in colorful plant foods known for their antioxidant and anti-inflammatory properties.
What made this study unique is how it measured not just the amount of flavonoids people consumed, but also the diversity—meaning how many different types of flavonoids they were getting from various foods. The researchers used mathematical tools to calculate dietary diversity and then analyzed how this related to the risk of developing chronic illnesses over time.
Participants with the highest diversity of flavonoid intake had:
14% lower risk of dying from any cause
10% lower risk of cardiovascular disease
20% lower risk of type 2 diabetes
8% lower risk of cancer
8% lower risk of respiratory disease
In short, people who ate a greater variety of flavonoids—regardless of the amount—tended to live longer and had lower rates of chronic conditions like cancer. The protective effect was strongest in people who consumed both a high quantity and high diversity of flavonoids.
Like all observational studies, this one can't prove cause and effect. The data came from self-reported dietary questionnaires, which are prone to some reporting error. The study also didn't include certain types of flavonoid-rich foods (like specific berries), which may underestimate true intake. And since the UK Biobank participants are not fully representative of the general population, more research is needed to confirm these findings across different groups.
We know that eating more plant-based foods is good for your health—but this study adds a new layer: variety matters. Researchers found that people who ate a greater diversity of flavonoid-rich foods had a lower risk of cancer and other chronic illnesses, even after accounting for other health behaviors. That means it's not just about drinking green tea every day or always grabbing the same apple—it's about mixing it up.
So what does a flavonoid-rich, diverse day actually look like? You might start with a cup of black tea and a handful of berries at breakfast, enjoy an apple or some citrus at lunch, then add red grapes to your dinner salad. The more different sources you include, the more types of flavonoids you're getting—and the stronger the potential protective effect.
Tea, berries, apples, oranges and grapes were among the top contributors to flavonoid intake in the study, but they're just the beginning. Think about how you can rotate these in and out of your week. Swapping strawberries for blueberries, choosing an orange over apple slices, or enjoying a piece of dark chocolate after dinner are all small moves that can add up.
It's also worth considering the flip side: when your diets lack diversity—especially in fruits and vegetables—you may be missing out on protective compounds that could lower your risk of cancer and other chronic conditions. This study suggests that eating the same thing every day, even if it's healthy, might not offer the full range of benefits.
The good news? Building diversity into your diet doesn't require a complete overhaul. Start by looking at your weekly grocery list or what's in your fruit bowl. Are there a few new things you can try? A wider range of colors usually means a wider range of nutrients—and this study suggests that could mean stronger disease protection, too.
Related: We Should Be Eating 30 Plants a Week, According to a Gastroenterologist. Here's How to Do It
A large new study suggests that eating a greater variety of flavonoid-rich foods—like tea, berries, apples, oranges and grapes—may lower your risk of cancer and other major chronic diseases. The greatest protection came from combining high quantity with high diversity. Small, simple shifts toward more colorful, plant-forward meals could support your long-term health in powerful ways.
Read the original article on EATINGWELL
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ob Hospitalist Group Expands Access to High-Risk Pregnancy Care with Launch of Obtelecare
Ob Hospitalist Group Expands Access to High-Risk Pregnancy Care with Launch of Obtelecare

Yahoo

time12 minutes ago

  • Yahoo

Ob Hospitalist Group Expands Access to High-Risk Pregnancy Care with Launch of Obtelecare

Newly branded telehealth solution builds on OBHG's longstanding commitment to high-risk pregnancy care in hospitals and clinics nationwide GREENVILLE, S.C., Aug. 4, 2025 /PRNewswire/ -- Ob Hospitalist Group (OBHG), the nation's largest and only dedicated provider of comprehensive obstetric solutions, is proud to introduce Obtelecare, a newly branded virtual maternal–fetal medicine (MFM) service. As an expansion of OBHG's high-risk pregnancy capabilities, Obtelecare provides hospitals, health systems and clinics with continuous access to MFM care through telephonic support, virtual consultations, and remote monitoring. This enhanced offering strengthens OBHG's commitment to improving access to high-risk pregnancy care, especially in communities facing provider shortages or coverage gaps. Currently, there are fewer than 2,500 MFMs serving the entire country, creating significant gaps in care and limited availability of MFM services. At the same time, risk factors for high–risk pregnancies, such as hypertension, diabetes, obesity, and advanced maternal age, are on the rise. Obtelecare is a telehealth solution that extends the reach of MFM specialists, enabling earlier interventions through virtual consultations. The service allows MFMs to collaborate with the patient, OB–GYNs, hospitalists, nurses, and other onsite providers to develop a care plan in real time, which is then deployed by providers onsite. "Obtelecare represents the next evolution of our mission to ensure every mother has access to the level of care she needs, when she needs it," said Nick Sacco, President and Chief Operating Officer of OBHG. "While the name is new, Obtelecare builds on the high-risk care we've long provided to the communities we serve. This launch represents a meaningful investment in expanding our care model to address a critical gap in maternal-fetal medicine access. Building on almost 20 years of expanding access to high–quality obstetric and midwifery care through our proven OB hospitalist model, we're now extending our services to include virtual maternal–fetal medicine. By breaking down geographic barriers in communities across the U.S., Obtelecare will open doors to MFM expertise in markets that have historically struggled to recruit specialists—ultimately leading to safer pregnancies, healthier babies, and stronger communities." Available nationwide, the program offers a fully customizable and scalable solution for health systems, hospital and clinics. Built on OBHG's proven capabilities, it enhances care by enabling earlier interventions and improving coordination between onsite clinical teams and remote MFM experts, all while integrating smoothly into existing workflows to support better outcomes for high-risk pregnancies. "The rise in high–risk pregnancies has led to a growing demand for MFM specialists, outpacing the current supply of clinicians and creating significant gaps in the availability of MFM services," said Rebecca Flack, Senior Vice President of Telehealth at OBHG. "For complex pregnancies, timely access to an MFM isn't just beneficial — it can be lifesaving. With Obtelecare, Ob Hospitalist Group is closing critical gaps in care and bringing expert–level support to patients and providers in underserved or under-resourced areas." For more information about Obtelecare and how health systems can partner with OBHG, visit About ObtelecareObtelecare, part of Ob Hospitalist Group's comprehensive suite of obstetric solutions, delivers real-time collaboration between onsite clinicians and maternal-fetal medicine (MFM) specialists through advanced telehealth technology. Within minutes, MFM experts can consult on complex pregnancies, engage with both patients and providers, and create personalized care plans for local clinical teams to implement. This seamless connection empowers hospitals - especially those without in-house MFM coverage - to deliver expert-level care, reduce unnecessary patient transfers, and keep families close to home. Fully integrated into hospital workflows, Obtelecare advances maternal care by enhancing safety, improving efficiency, and expanding access to high-risk pregnancy expertise. Visit About Ob Hospitalist GroupOb Hospitalist Group (OBHG) is the nation's largest provider of OB/GYNs and the leading provider of customized women's health solutions. Through its core OB hospitalist programs and Maternal Health Access Solutions (MHAS), OBHG delivers expert obstetric care in hospitals nationwide. We partner with hospitals nationwide to improve maternal safety, reduce physician burnout and expand or restore access to care. With nearly 2,000 clinicians collaborating closely with local OB/GYNs, OBHG ensures timely, expert care for every pregnant woman. OBHG is headquartered in Greenville, SC. Visit Contact: Amy BomarDirector of Marketing800.967.2289abomar@ View original content to download multimedia: SOURCE Ob Hospitalist Group Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Major increase in colorectal cancer in younger adults tied to pandemic years, researchers say
Major increase in colorectal cancer in younger adults tied to pandemic years, researchers say

Yahoo

time12 minutes ago

  • Yahoo

Major increase in colorectal cancer in younger adults tied to pandemic years, researchers say

New research on colorectal cancer rates in the U.S. has found that rates in younger adults increased 'steeply' before and during the early years of the Covid pandemic. There was a 50 percent relative increase between 2021 and 2022, according to the American Cancer Society. 'This trend contrasts with consistent increases of distant-stage diagnoses in this age group and likely reflects diagnosis of prevalent asymptomatic cancer through first-time screening due to recommendations for adults to begin screening at age 45 instead of age 50,' the authors said in a statement. The recommended age was lowered in 2021, in response to rising cases. Doctors hoped that doing so would encourage more screenings and help people to catch the cancer early. Screening is usually done as a colonoscopy through a primary care physician. Treatment is more successful earlier on than in later stages of the disease. 'Colorectal cancer is a devastating disease and the third leading cause of cancer deaths in the United States, yet about a quarter of adults ages 50 to 75 have never been screened for colorectal cancer. The Task Force reviews its recommendations about every five years to make sure they reflect the latest research,' Martha Kubik, registered nurse and U.S. Preventive Services Task Force member, told Healio then. 'By reducing the screening age, hopefully you capture more people as they're entering 50 than you ever did before,' Dr. Rachel Issaka, a gastroenterologist and assistant professor with UW Medicine, said then. Colorectal cancer deaths have surged since 2021. Last year, there were an estimated 152,810 new cases and 53,010 deaths. Whereas in 2023, there were an estimated 52,550 deaths, according to the Colorectal Cancer Alliance. This year, the American Cancer Society projects there will be more than 154,000 cases. Early onset cases have risen in the U.S. and around the world, and nearly double the number of young adults under the age of 55 years old are being diagnosed with colorectal cancer compared to a decade ago, according to the American Cancer Society. Since the mid-1990s, there has been a consistent annual increase of two percent in cases among American adults between the ages of 20 and 39, the Cancer Research Institute reports. Doctors have multiple theories for what's happening, with recent studies linking increased U.S. cases to poor nutritional health and a toxin in the gut. But, researchers still have not found a concrete answer and upward trends are projected to continue. By 2030, Issaka says colorectal cancer is predicted to be the leading cause of cancer death for people under 50. 'We really need to have people understand that colorectal cancer isn't an old people's disease anymore,' she said. The new research was published on Monday in the journal JAMA Network. The study was released alongside two others that looked at trends in screening and screening strategies. The other research saw screening rates also increasing among the same age group, which was consistent with a previous report. But, a March survey commissioned by the Colorectal Cancer Alliance found more than half of adults prioritize household chores over getting a possibly life-saving colorectal cancer screening. 'These results reveal a life-threatening gap in public awareness of colorectal cancer,' Dr. Christopher Lieu, a medical oncologist and advisor to the Colorectal Cancer Alliance, said in a statement.

As more young people get screened, more colon cancer is being found early. Here's how to lower your risk
As more young people get screened, more colon cancer is being found early. Here's how to lower your risk

CNN

time13 minutes ago

  • CNN

As more young people get screened, more colon cancer is being found early. Here's how to lower your risk

Even more colorectal cancer cases are being found in adults under 50, and a new collection of research suggests that a surge in screening may be tied to many of the more recent diagnoses – but not the overall trend. In 2018, the American Cancer Society updated its guidelines for colon and rectal cancer screening, recommending that adults at average risk get screened starting at age 45 – earlier than 50, which was previously advised. Then, in 2021, the US Preventive Services Task force also lowered the recommended age to start screening for colon and rectal cancers from 50 to 45. The shift in screening guidelines is associated with a recent increase in early-stage colorectal cancer diagnoses, but it does not explain the rise among younger adults in general – a trend that began in the mid-1990s and includes late-stage cancers, as well. Colorectal cancer refers to colon cancer, which starts in the colon, and rectal cancer, which starts in the rectum. 'The drivers of rising incidence are still unknown, but many research efforts are ongoing, with investigations covering the gamut from microplastics to ultra processed food and many other gut exposures introduced in the last half of the 20th century, when this began,' Elizabeth Schafer, associate scientist of surveillance and health equity science at the American Cancer Society, said in an email. Lowering the screening age 'has likely facilitated earlier detection of cancers that might have been missed,' but there is still more work to do to identify the driving factors behind the ongoing overall rise of colorectal cancer in younger ages, Dr. Joseph Rinaldi, a gastroenterologist at Montefiore Einstein Comprehensive Cancer Center, said in an email. 'It is likely that factors beyond screening guidelines are contributing to the overall rise in colorectal cancer incidence,' Rinaldi said. 'Much work remains to identify causal factors – whether environmental, genetic, or population-based – that can be targeted for prevention and, potentially, reversal of this trend.' Now, research conducted by the American Cancer Society that was published Monday in the medical journal JAMA found that the share of US adults ages 45 to 49 who are up to date on colorectal cancer screening climbed from 20.8% in 2019 and 19.7% in 2021 to 33.7% in 2023. 'We've been waiting for screening to take off in this age group,' Schafer, an author on the new screening study, said in the email. 'But the real thrill is the translation to early diagnosis, which means less intense treatment and lives saved.' A second study, also conducted by the American Cancer Society and published Monday in JAMA, found that the prevalence of early-stage colorectal cancer diagnoses among adults 45 to 49 increased from 9.4 cases per 100,000 people in 2019 to 11.7 per 100,000 in 2021 and then to 17.5 per 100,000 in 2022. That translates to a 50% relative increase between 2021 and 2022. 'If screening was the cause of the rise, the increase would have been for early- instead of late-stage disease,' said Schafer, lead author of the second paper. 'Local stage diagnosis was rare in this age group before screening because there are usually no symptoms yet,' Schafer said of early-stage cancers that have not spread to other parts of the body. 'So yes, it was a bit shocking, actually, to see early-stage incidence double from 9.4 to 17.5 per 100,000 in this newly screened group.' As a rise in colon and rectal cancers persists among younger adults, public health experts now urge them to know the warning signs and to get screened when eligible. More than half of the people who are diagnosed with colorectal cancer before 50 are not eligible for screening because they haven't yet reached the recommended age of 45. And most people who are eligible have still not been screened, said Jessica Star, associate scientist of cancer risk factors and screening surveillance research at the American Cancer Society, who was lead author on the new screening study and an author on the other paper. Whether someone is recommended for screening or not, they should still watch for signs and symptoms of colorectal cancer and talk with their doctor if they notice any, she said. In the United States, about 1 in 23 men and 1 in 25 women will be diagnosed with colorectal cancer in their lifetime. The most common symptom is rectal bleeding,' Star said in an email, adding that 41% of patients under 50 tend to experience this symptom, compared with 26% of patients older than 50. Many people also may have abdominal cramping or pain. 'Young people, especially, are reluctant to talk about these types of symptoms, but it could actually save their life,' Star said. 'Other important symptoms include a persistent change in bowel habits or the shape of stool, decreased appetite, and weight loss. People with any of these symptoms that persist for several weeks should be followed up with a doctor's visit,' she said. 'If you are young and your concerns are not being addressed, get a second opinion. There are too many stories about young people being told they have hemorrhoids, finding out months or years later that it is cancer.' When Kelly Spill, 33, experienced symptoms of colorectal cancer after the birth of her first child, she said, her doctors told her that they were tied to being postpartum and internal hemorrhoids. 'One day I went to the bathroom, and I looked down, and you would have thought it was my time of the month, and it most certainly was not. That's when it became extremely alarming,' Spill told CNN in May of the blood in her stool. When she noticed massive amounts of blood again, she took photos and showed them to a primary care physician. The doctor immediately ordered a colonoscopy, and that's what led to her being diagnosed with stage III rectal cancer at age 28 in 2020. 'To self-advocate is such a big one,' Spill said. 'If I didn't push, push, push, I don't know where I would be, and especially as a new mom.' Spill was treated with an immunotherapy drug called dostarlimab and is now a healthy mother of three. She remains cancer-free. Getting screened can help reduce the risk of colorectal cancer, because almost all colorectal cancers begin as precancerous polyps in the colon or rectum. But through screening, these polyps can be identified and removed before they turn cancerous. Current options for colorectal cancer screening for people at average risk include a stool-based fecal test either annually or every three years; a traditional colonoscopy every 10 years; a virtual colonoscopy every five years; or a sigmoidoscopy procedure, which involves using a tube-like instrument called an endoscope to examine the lower part of the colon, every five years. A separate study published Monday in JAMA found that when people newly eligible for screening were automatically mailed a fecal test kit at their home address without asking for it, they were more likely to complete screening than those who were asked to actively choose between a colonoscopy, a fecal test or deferring screening altogether. 'Another important question is how to get more people screened, especially people without access to healthcare, a group that had no significant increase in screening in our study,' Schafer, who was not involved in that study, said in the email. Despite recent increases in screening, it's still estimated that more than 1 in 3 adults 45 and older are not getting screened as recommended, according to the National Colorectal Cancer Roundtable. There are other steps people can take to help prevent colorectal cancer. 'There are many things people of all ages can do to reduce their risk, including not smoking, maintaining a healthy body weight, being physically active, avoiding excessive alcohol consumption, and eating a healthy diet that is low in red and processed meat and high in whole grains, fruits, and vegetables,' Star said. More than half of all colorectal cancers in the US are attributable to those modifiable risk factors, according to the American Cancer Society. 'There have been several studies that work to identify factors contributing to the development of colon cancer. Maintaining a physically active lifestyle and a healthy weight is important, as obesity has been linked to early-onset disease,' Rinaldi said. 'I also encourage avoiding tobacco, refined grains, and sugary beverages and instead focus on consuming a fiber-rich diet that is more plant-based and that limits the consumption of red and processed meats, as this is thought to be protective to colon health.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store